8DAF
Human SF-1 LBD bound to synthetic agonist 6N-10CA and bacterial phospholipid
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-ID |
Synchrotron site | APS |
Beamline | 22-ID |
Temperature [K] | 80 |
Detector technology | PIXEL |
Collection date | 2020-07-19 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 1 |
Spacegroup name | P 31 2 1 |
Unit cell lengths | 73.428, 73.428, 194.184 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 38.590 - 2.590 |
R-factor | 0.2255 |
Rwork | 0.223 |
R-free | 0.28120 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1zdt |
RMSD bond length | 0.006 |
RMSD bond angle | 0.696 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 38.590 | 2.680 |
High resolution limit [Å] | 2.590 | 2.590 |
Rpim | 0.035 | 0.453 |
Number of reflections | 19623 | 1878 |
<I/σ(I)> | 13.5 | |
Completeness [%] | 99.8 | |
Redundancy | 12.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 277.15 | Na acetate (pH 4.6), glycerol, PEG 4000 |